Form 4: Astronics Executive Gifts Shares, Maintains Substantial Equity
Insider Transaction Report
Astronics Corp. Executive VP Mark Peabody reported gifting 450 common shares while retaining significant equity holdings, including performance-based restricted stock units and options.
Summary
- Mark Peabody, Executive VP & President-Aerospace of Astronics Corp (ATRO), reported a transaction on August 13, 2025.
- He disposed of 450 shares of $.01 PV Common Stock via a gift (transaction code 'G').
- Following this transaction, Peabody directly beneficially owns 49,544.73 shares of $.01 PV Common Stock and 183,994 shares of $.01 PV Class B Stock.
- He also holds a substantial number of derivative securities, including various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates up to December 16, 2032.
- Additionally, Peabody holds Restricted Stock Units (RSUs) with target numbers of 15,900, 10,850, and 15,150 shares, whose vesting is tied to Astronics Corp.'s average annual adjusted EBITDA performance over future periods.
Sentiment
Score: 6
Explanation: The filing reports a minor gift of shares by an executive, which is offset by substantial remaining equity holdings, including performance-based options and restricted stock units, indicating continued alignment with company performance.
Positives
- Continued significant equity alignment of a key executive with shareholder interests through substantial holdings of stock options and performance-based Restricted Stock Units.
- The performance-based vesting of RSUs (tied to average annual adjusted EBITDA) incentivizes management to achieve specific financial targets over multi-year periods (e.g., 2024-2026, 2023-2025, 2025-2027).
Negatives
- A small reduction in direct common stock ownership by a key executive due to a gift of 450 shares.
Risks
- Vesting of a significant portion of the executive's Restricted Stock Units (RSUs) is contingent on Astronics Corp.'s achievement of specific average annual adjusted EBITDA targets for the periods January 1, 2023-December 31, 2025, January 1, 2024-December 31, 2026, and January 1, 2025-December 31, 2027. Failure to meet these targets could result in a lower vesting percentage (between 50% and 150% of target for some, 75% and 115% for others).
Future Outlook
The future outlook for a significant portion of executive compensation is directly tied to Astronics Corp.'s ability to achieve specific average annual adjusted EBITDA targets over the next several years, with vesting periods for Restricted Stock Units extending to 2028.
Industry Context
N/A
Stakeholder Impact
- Shareholders: Minimal direct impact from the small gift of shares. Continued executive alignment through performance-based equity awards is generally positive for long-term shareholder value.
Next Steps
- Astronics Corp. management will focus on achieving average annual adjusted EBITDA targets for the periods 2023-2025, 2024-2026, and 2025-2027 to ensure vesting of performance-based Restricted Stock Units.
- The executive may exercise various stock options as they become more in-the-money or approach their expiration dates.
- Restricted Stock Units are scheduled to potentially vest on February 23, 2026, February 22, 2027, and February 27, 2028, based on performance.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Date exercisable for options with $27.72 exercise price |
| 12/14/2017 | Date exercisable for options with $31.76 exercise price |
| 12/12/2018 | Date exercisable for options with $35.61 exercise price |
| 12/13/2019 | Date exercisable for options with $31.57 exercise price |
| 12/09/2020 | Date exercisable for options with $30.04 exercise price |
| 01/22/2022 | Date exercisable for options with $14.45 exercise price |
| 12/09/2022 | Date exercisable for options with $11.13 exercise price |
| 01/01/2023 | Start of performance period for 10,850 target Restricted Stock Units |
| 12/16/2023 | Date exercisable for options with $9.74 exercise price |
| 01/01/2024 | Start of performance period for 15,900 target Restricted Stock Units |
| 12/07/2024 | Date exercisable for options with $15.15 exercise price |
| 01/01/2025 | Start of performance period for 15,150 target Restricted Stock Units |
| 08/13/2025 | Transaction Date: Gift of 450 shares of common stock |
| 08/28/2025 | Signature Date of the Form 4 filing |
| 12/03/2025 | Expiration Date for options with $27.72 exercise price |
| 12/31/2025 | End of performance period for 10,850 target Restricted Stock Units |
| 02/23/2026 | Potential vesting date for 10,850 target Restricted Stock Units |
| 12/14/2026 | Expiration Date for options with $31.76 exercise price |
| 12/31/2026 | End of performance period for 15,900 target Restricted Stock Units |
| 02/22/2027 | Potential vesting date for 15,900 target Restricted Stock Units |
| 12/12/2027 | Expiration Date for options with $35.61 exercise price |
| 12/31/2027 | End of performance period for 15,150 target Restricted Stock Units |
| 02/27/2028 | Potential vesting date for 15,150 target Restricted Stock Units |
| 12/13/2028 | Expiration Date for options with $31.57 exercise price |
| 12/09/2029 | Expiration Date for options with $30.04 exercise price |
| 01/22/2031 | Expiration Date for options with $14.45 exercise price |
| 12/09/2031 | Expiration Date for options with $11.13 exercise price |
| 12/16/2032 | Expiration Date for options with $9.74 exercise price |
| 12/07/2033 | Expiration Date for options with $15.15 exercise price |
Recommendation
holdThis Form 4 filing details a minor gift of shares by an executive, which is a routine insider transaction and does not materially alter the investment thesis for Astronics Corp. The executive retains substantial equity holdings, including performance-based awards, suggesting continued alignment with long-term company performance. Without further financial or strategic updates, a 'hold' recommendation is appropriate as this filing alone does not provide sufficient new information to warrant a change in investment stance.
Keywords
Astronics Corp, ATRO, Mark Peabody, insider transaction, Form 4, executive compensation, stock options, restricted stock units, EBITDA targets, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.